TEMPLE CITY, Calif., Dec. 29, 2020 (GLOBE NEWSWIRE) --Fulgent Genetics, Inc(Nasdaq: FLGT), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced that the Company has extended...
The call may be accessed through a live audio webcast on the Investor Relations section of the company’s website, http://ir.fulgentgenetics.com. An audio replay will be available at the same location. Note Regarding Non-GAAP Financial Measures Certain information set forth in this press rel...
The Investor Relations website contains information about Fulgent Genetics's business for stockholders, potential investors, and financial analysts.
Fulgent Genetics, Inc. today announced it has launched a test for monkeypox that leverages the U.S. Centers for Disease Control and Prevention’s (CDC) orthopoxvirus test.